Data as of Jul 30
| +0.17 / +2.28%|
The 7 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 6.00. The median estimate represents a +31.23% increase from the last price of 7.62.
The current consensus among 7 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.